Skip to main content

UBS Group AG

Position in IGC — IGC Pharma, Inc.

CIK 1610520 ZURICH, V8

Position in IGC

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$0
-$2,104 QoQ
Shares Held
1
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IGC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,173,310 across 562 Biotechnology names. IGC ranks #557 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in IGC

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $0 1
2026-03-31 $2,104 8,097
2025-12-31 $5,562 19,869
2025-09-30 $1,278 3,045
2025-06-30 $11,255 36,308
2025-03-31 $0 1
2024-12-31 $1,060 3,118
2023-12-31 $1,328 4,747
2023-09-30 $105 294
2023-06-30 $91 294
2023-03-31 $99 294
2022-12-31 $94 294
2022-09-30 $126 294
2022-06-30 $8,574 16,179
2022-03-31 $12,302 12,950
2021-12-31 $15,138 15,447
2021-09-30 $82,623 55,827
2021-06-30 $13,821 8,428
2021-03-31 $2,489 1,391
2020-12-31 $47,057 30,165
2020-09-30 $14,723 14,157
2020-03-31 $178 365